Cochrane Abstracts
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long-term Proton Pump Inhibitor (PPI) Use and the Development of Gastric Pre-malignant Lesions: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431008/all/Unit‐dose_packaged_drugs_for_treating_malaria_Unchanged. Accessed 04 October 2023.
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431008/all/Unit‐dose_packaged_drugs_for_treating_malaria_Unchanged. Accessed October 4, 2023.
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431008/all/Unit‐dose_packaged_drugs_for_treating_malaria_Unchanged
Long-term Proton Pump Inhibitor (PPI) Use and the Development of Gastric Pre-malignant Lesions: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431008/all/Unit‐dose_packaged_drugs_for_treating_malaria_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions: Cochrane systematic review
ID - 431008
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431008/all/Unit‐dose_packaged_drugs_for_treating_malaria_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -
